| Literature DB >> 27347425 |
Barry A Cohen1, Mark J Courtney2, Louise M Moist3, James Barton4.
Abstract
BACKGROUND: A critical feature of any continuing medical education (CME) program is the inclusion of a needs assessment for its target audience. This assessment must identify both perceived and unperceived needs, so as to best capture the entire spectrum of learning opportunities for the group.Entities:
Keywords: Continuing medical education; Environmental scan; Needs assessment; Nephrology; Perceived needs; Questionnaire; Unperceived needs
Year: 2016 PMID: 27347425 PMCID: PMC4919888 DOI: 10.1186/s40697-016-0121-x
Source DB: PubMed Journal: Can J Kidney Health Dis ISSN: 2054-3581
Acceptable guideline target achievement rates by parameter, within dialysis units
| Parameter | Acceptable guideline target achievement rate (%) |
|---|---|
| Prevalent HD pts using fistulae | >51.0 |
| Prevalent HD pts using catheters | <31.9 |
| Prevalent HD pts monitored via Qa | >68.4 |
| Prevalent HD pts monitored via Recirc | >39.4 |
| Prevalent HD pts not monitored | <15.3 |
| Prevalent HD pts with sessional Kt/V >1.2 | >71.4 |
| Prevalent PD pts with weekly Kt/V (PD + renal) >1.7 | >66.5 |
| Prevalent dialysis pts; [Hgb] 100–120 g/L | >57.5 |
| Prevalent dialysis pts; tsat 20–50 % | >54.8 |
| Prevalent dialysis pts; [ferritin] 100–800 ng/mL | >58.0 |
| Prevalent dialysis pts; [Ca] 2.1–2.54 mmol/L | >58.8 |
| Prevalent dialysis pts; [PO4] 1.13–1.78 mmol/L | >52.0 |
| Prevalent dialysis pts; [PTH] 16.5–33.0 pmol/L | >51.7 |
| Prevalent dialysis pts; 0 in target | <15.5 |
| Prevalent dialysis pts; HgbA1c <7.0 % | >44.7 |
Abbreviations: HD pts hemodialysis patients, PD pts peritoneal dialysis patients, Qa access flow technique, Recirc recirculation measurement, [Hgb] predialysis hemoglobin concentration, tsat transferrin saturation, [ferritin] ferritin concentration, [Ca] predialysis corrected calcium concentration, [PO4] predialysis phosphate concentration, [PTH] parathormone concentration, 0 in target percentage of patients with zero mineral metabolism parameters ([Ca], [PO4], [PTH]) within the target range
Perceived needs assessment for the 2016 CSN AGM
| Rank | Topic | Votes | % of all votes |
|---|---|---|---|
| 1 | Volume Status and Hypertension in Dialysis | 40 | 23.4 |
| 2 | Dialysis Access – Infectious Complications (HD and PD) | 31 | 18.0 |
| 3 | Dialysis Program Administration | 30 | 17.5 |
| 4 | Cardiovascular Disease in CKD and Dialysis | 27 | 15.8 |
| 4 | Hemodialysis Access – timing, selection, surveillance, intervention | 27 | 15.8 |
| 6 | Outcomes in Dialysis including Adequacy and Timing | 24 | 14.0 |
| 7 | Dialysis Modality Selection | 21 | 12.3 |
| 8 | Nocturnal/Quotidian Dialysis | 20 | 11.7 |
| 9 | Exercise/Rehab in CKD and Dialysis | 18 | 10.5 |
| 10 | Anemia Management in CKD and Dialysis | 17 | 9.9 |
| 10 | Mineral Metabolism in CKD and Dialysis | 17 | 9.9 |
| 12 | Nutrition in CKD and Dialysis | 15 | 8.8 |
| 13 | Metabolic Issues in CKD and Dialysis – lipids, diabetes | 12 | 7.0 |
| 14 | Psychosocial Issues and Palliative Care in Nephrology | 11 | 6.4 |
| 15 | OTHER: “PD” | 4 | 2.3 |
| 16 | OTHER: Acute Dialysis Modality Selection | 2 | 1.8 |
Chronic dialysis topics
Perceived needs assessment for the 2016 CSN AGM
| Rank | Topic | Votes | % of all votes |
|---|---|---|---|
| 1 | Secondary GN | 40 | 23.4 |
| 2 | General CKD prevention – proteinuria, lipids, BP | 37 | 21.6 |
| 3 | Primary GN | 35 | 20.4 |
| 4 | Transplant Issues for the General Nephrologist | 33 | 19.3 |
| 5 | Fluids/Electrolytes/Acid-base | 32 | 18.7 |
| 6 | Geriatric Nephrology | 31 | 18.0 |
| 7 | Ethics in Nephrology | 29 | 17.0 |
| 8 | Pregnancy and Renal Disease | 28 | 16.4 |
| 9 | Tubulointerstitial Nephritis | 21 | 12.3 |
| 10 | Ischemic Nephropathy and Renovascular Hypertension | 20 | 11.7 |
| 11 | ARF/AKI – Staging and Therapy | 19 | 11.1 |
| 12 | Diabetic Nephropathy | 18 | 10.5 |
| 13 | Essential Hypertension | 17 | 9.9 |
| 13 | Genetic Diseases including PCKD | 17 | 9.9 |
| 13 | Radiographic Interventions and the Kidney | 17 | 9.9 |
| 16 | Thrombotic Microangiopathy | 16 | 9.4 |
| 16 | Nephrolithiasis | 16 | 9.4 |
| 16 | Management of Overdoses | 16 | 9.4 |
| 19 | General CKD Staging – Scr, Ccr, Cockcroft-Gault, eGFR | 12 | 7.0 |
| 20 | OTHER: CAKUT | 4 | 2.3 |
| 20 | OTHER: CKD Screening | 4 | 2.3 |
| 20 | OTHER: Renal Pathology | 4 | 2.3 |
| 23 | OTHER: Onconephrology | 1 | 0.6 |
| 23 | OTHER: CQI | 1 | 0.6 |
General nephrology topics
Unperceived needs assessment for the 2016 CSN AGM—achievement rates for various guidelines targets
| Parameter | Centers submitting data | Centers with an acceptable guideline target achievement rate | Percentage of centers with an acceptable guideline target achievement rate |
|---|---|---|---|
| 1. HD access | |||
| AVF rate | 76 | 23 | 30.2 |
| Catheter rate | 76 | 6 | 7.9 |
|
| 152 | 29 |
|
| 2. Access monitoring | |||
| AVF—Qa | 76 | 46 | 60.5 |
| AVF—Recirc | 76 | 24 | 31.6 |
| AVF—NM | 76 | 49 | 64.5 |
| AVG—Qa | 57 | 40 | 70.2 |
| AVG—Recirc | 57 | 19 | 33.3 |
| AVG—NM | 57 | 46 | 80.1 |
|
| 399 | 224 |
|
| 3. Adequacy | |||
| HD | 75 | 36 | 48.0 |
| PD | 38 | 36 | 94.7 |
|
| 113 | 72 |
|
| 4. Anemia | |||
| [Hgb]—HD | 76 | 56 | 73.7 |
| Tsat—HD | 76 | 70 | 92.1 |
| [ferritin]—HD | 74 | 55 | 74.3 |
| [Hgb]—PD | 51 | 22 | 43.1 |
| Tsat—PD | 50 | 48 | 96.0 |
| [ferritin]—PD | 50 | 46 | 92.0 |
|
| 377 | 297 |
|
| 5. MM | |||
| [Ca]—HD | 76 | 69 | 90.8 |
| [PO4]—HD | 76 | 19 | 25.0 |
| [PTH]—HD | 76 | 0 | 0.0 |
| 0 in target—HD | 76 | 55 | 72.4 |
| [Ca]—PD | 51 | 41 | 80.4 |
| [PO4]—PD | 51 | 29 | 56.9 |
| [PTH]—PD | 50 | 1 | 2.0 |
| 0 in target—PD | 50 | 39 | 78.0 |
|
| 506 | 253 |
|
| 6. DM | |||
| HgbA1c—HD | 75 | 66 | 88.0 |
| HgbA1c—PD | 51 | 31 | 60.8 |
|
| 126 | 97 |
|
Abbreviations: HD hemodialysis, PD peritoneal dialysis, AVF arteriovenous fistula, AVG arteriovenous graft, Qa access flow technique, Recirc recirculation measurement, NM not monitored, [Hgb] predialysis hemoglobin concentration, Tsat transferrin saturation, MM mineral metabolism, [Ca] predialyis corrected calcium concentration, [PO4] predialysis phosphate concentration, [PTH] parathormone concentration, 0 in target number of centers with zero mineral metabolism parameters within the target range, DM diabetes mellitus
Triangulation of needs assessment for dialysis topics
| Survey | Achievement of guideline targets | |
|---|---|---|
| Vascular access type | High needs | High needs |
| Access monitoring | High needs | Intermediate needs |
| Adequacy | Intermediate needs | Intermediate needs |
| Mineral metabolism | Low needs | Intermediate needs |
| Metabolic issues (DM) | Low needs | Low needs |
| Anemia management | Low needs | Low needs |